Market Cap 679.18M
Revenue (ttm) 2.73B
Net Income (ttm) -1.13B
EPS (ttm) N/A
PE Ratio 8.06
Forward PE 5.68
Profit Margin -41.45%
Debt to Equity Ratio 1.45
Volume 2,060,850
Avg Vol 2,371,050
Day's Range N/A - N/A
Shares Out 68.19M
Stochastic %K 41%
Beta 0.75
Analysts Hold
Price Target $17.30

Company Profile

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibo...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 552 1100
Fax: 858 453 4338
Address:
9975 Summers Ridge Road, San Diego, United States
SQUEAKSBANDIT
SQUEAKSBANDIT May. 13 at 9:17 PM
$QDEL https://valueinvesting.io/QDEL/probability-of-bankruptcy they say 49% of a bk filing in 2yr take it FWIW
0 · Reply
looking4aprty
looking4aprty May. 12 at 2:37 PM
$QDEL you sure its going down because it looks like QDEL is headed towards 20 dollars man i hope you know what you're talking about and if you're short good luck
1 · Reply
Staska
Staska May. 12 at 2:35 PM
$QDEL https://seekingalpha.com/article/4902804-quidelortho-a-growing-stable-business-with-a-significant-mispricing
0 · Reply
looking4aprty
looking4aprty May. 12 at 2:34 PM
0 · Reply
looking4aprty
looking4aprty May. 12 at 2:34 PM
$QDEL im not sure but it looks like it about to take off
0 · Reply
gvnbykplt1903
gvnbykplt1903 May. 11 at 7:48 PM
0 · Reply
BullYa
BullYa May. 11 at 7:47 PM
$QDEL 📉 single digit is arriving 📉🔥
0 · Reply
scott52
scott52 May. 11 at 4:33 PM
$QDEL Damn. Will this thing ever stop going down? Glad i don't own it. But curious if/when it hits a buy point. Anyone? thoughts? Is there a price it becomes a must buy?
0 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 12:44 PM
$QDEL Current Stock Price: $10.80 Contracts to trade: $10.0 QDEL May 15 2026 Call Entry: $1.07 Exit: $1.96 ROI: 83% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
anachartanalyst
anachartanalyst May. 7 at 1:02 PM
$QDEL https://anachart.com/wp-content/uploads/2026/05/1778158890_soc-img.jpg
0 · Reply
Latest News on QDEL
QuidelOrtho price target lowered to $11 from $15 at JPMorgan

2026-05-07T17:03:10.000Z - 6 days ago

QuidelOrtho price target lowered to $11 from $15 at JPMorgan


QuidelOrtho price target lowered to $12 from $17 at UBS

2026-05-07T13:04:54.000Z - 6 days ago

QuidelOrtho price target lowered to $12 from $17 at UBS


QuidelOrtho downgraded to Hold from Buy at Jefferies

2026-05-07T12:23:05.000Z - 6 days ago

QuidelOrtho downgraded to Hold from Buy at Jefferies


QuidelOrtho price target lowered to $13 from $30 at Citi

2026-05-07T08:47:43.000Z - 6 days ago

QuidelOrtho price target lowered to $13 from $30 at Citi


QuidelOrtho Earnings Call Transcript: Q1 2026

May 5, 2026, 5:00 PM EDT - 8 days ago

QuidelOrtho Earnings Call Transcript: Q1 2026


QuidelOrtho  reports adjusted Q1 EPS (4c), consensus 42c

2026-05-05T20:16:22.000Z - 8 days ago

QuidelOrtho reports adjusted Q1 EPS (4c), consensus 42c


QuidelOrtho Reports First Quarter 2026 Financial Results

May 5, 2026, 4:05 PM EDT - 8 days ago

QuidelOrtho Reports First Quarter 2026 Financial Results


TTP Group announces sale of LEX Diagnostics to QuidelOrtho

2026-04-20T13:22:22.000Z - 23 days ago

TTP Group announces sale of LEX Diagnostics to QuidelOrtho


TTP Group Announces the Sale of LEX Diagnostics

Apr 20, 2026, 7:56 AM EDT - 23 days ago

TTP Group Announces the Sale of LEX Diagnostics


QuidelOrtho completes acquisition of LEX Diagnostics

2026-04-20T11:15:22.000Z - 23 days ago

QuidelOrtho completes acquisition of LEX Diagnostics


QuidelOrtho sees Q1 revenue $615M-$620M, consensus $679.59M

2026-04-15T20:23:25.000Z - 4 weeks ago

QuidelOrtho sees Q1 revenue $615M-$620M, consensus $679.59M


QuidelOrtho sees Q1 free cash flow ($70M)-($65M)

2026-04-15T20:21:45.000Z - 4 weeks ago

QuidelOrtho sees Q1 free cash flow ($70M)-($65M)


QuidelOrtho price target lowered to $17 from $30 at UBS

2026-04-10T11:35:13.000Z - 4 weeks ago

QuidelOrtho price target lowered to $17 from $30 at UBS


QuidelOrtho names Nathaniel Sisitsky as Chief Legal Officer

2026-03-24T11:11:30.000Z - 7 weeks ago

QuidelOrtho names Nathaniel Sisitsky as Chief Legal Officer


Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer

Mar 24, 2026, 7:00 AM EDT - 7 weeks ago

Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer


Faster Cardiac Answers with High‑Sensitivity Troponin

Feb 19, 2026, 9:17 AM EST - 2 months ago

Faster Cardiac Answers with High‑Sensitivity Troponin


QuidelOrtho Earnings Call Transcript: Q4 2025

Feb 11, 2026, 5:00 PM EST - 3 months ago

QuidelOrtho Earnings Call Transcript: Q4 2025


Innovating Diagnostics and What's Next

Dec 18, 2025, 9:17 AM EST - 5 months ago

Innovating Diagnostics and What's Next


QuidelOrtho To Participate In Upcoming Investor Conferences

Nov 24, 2025, 7:00 AM EST - 6 months ago

QuidelOrtho To Participate In Upcoming Investor Conferences


The Power of Prevention: Detecting Diabetes Before It Strikes

Nov 20, 2025, 9:00 AM EST - 6 months ago

The Power of Prevention: Detecting Diabetes Before It Strikes


QuidelOrtho Earnings Call Transcript: Q3 2025

Nov 5, 2025, 5:00 PM EST - 6 months ago

QuidelOrtho Earnings Call Transcript: Q3 2025


QuidelOrtho Reports Third Quarter 2025 Financial Results

Nov 5, 2025, 4:05 PM EST - 6 months ago

QuidelOrtho Reports Third Quarter 2025 Financial Results


QuidelOrtho to Report Third Quarter 2025 Financial Results

Oct 22, 2025, 7:00 AM EDT - 7 months ago

QuidelOrtho to Report Third Quarter 2025 Financial Results


QuidelOrtho Transcript: Baird Global Healthcare Conference 2025

Sep 10, 2025, 3:10 PM EDT - 8 months ago

QuidelOrtho Transcript: Baird Global Healthcare Conference 2025


QuidelOrtho Completes Debt Refinancing

Aug 21, 2025, 4:30 PM EDT - 9 months ago

QuidelOrtho Completes Debt Refinancing


QuidelOrtho Launches Certified Analyzer Program

Aug 13, 2025, 3:00 PM EDT - 9 months ago

QuidelOrtho Launches Certified Analyzer Program


QuidelOrtho Earnings Call Transcript: Q2 2025

Aug 5, 2025, 5:00 PM EDT - 10 months ago

QuidelOrtho Earnings Call Transcript: Q2 2025


QuidelOrtho Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 4:10 PM EDT - 10 months ago

QuidelOrtho Reports Second Quarter 2025 Financial Results


QuidelOrtho to Report Second Quarter 2025 Financial Results

Jul 22, 2025, 4:30 PM EDT - 10 months ago

QuidelOrtho to Report Second Quarter 2025 Financial Results


Real Labs, Actual Decisions With Actionable Six Sigma Metrics

Jul 17, 2025, 7:00 AM EDT - 10 months ago

Real Labs, Actual Decisions With Actionable Six Sigma Metrics


QuidelOrtho Transcript: Strategy Update

Jun 3, 2025, 5:00 PM EDT - 1 year ago

QuidelOrtho Transcript: Strategy Update


QuidelOrtho to Participate in Upcoming Investor Conferences

May 22, 2025, 4:30 PM EDT - 1 year ago

QuidelOrtho to Participate in Upcoming Investor Conferences


QuidelOrtho Earnings Call Transcript: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

QuidelOrtho Earnings Call Transcript: Q1 2025


QuidelOrtho Reports First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 1 year ago

QuidelOrtho Reports First Quarter 2025 Financial Results


QuidelOrtho to Report First Quarter 2025 Financial Results

Apr 23, 2025, 4:30 PM EDT - 1 year ago

QuidelOrtho to Report First Quarter 2025 Financial Results


QuidelOrtho® Introduces Results Manager™ System

Mar 10, 2025, 9:00 AM EDT - 1 year ago

QuidelOrtho® Introduces Results Manager™ System


QuidelOrtho Earnings Call Transcript: Q4 2024

Feb 12, 2025, 5:00 PM EST - 1 year ago

QuidelOrtho Earnings Call Transcript: Q4 2024


QuidelOrtho Earnings Call Transcript: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

QuidelOrtho Earnings Call Transcript: Q3 2024


QuidelOrtho Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 4:05 PM EST - 1 year ago

QuidelOrtho Reports Third Quarter 2024 Financial Results


SQUEAKSBANDIT
SQUEAKSBANDIT May. 13 at 9:17 PM
$QDEL https://valueinvesting.io/QDEL/probability-of-bankruptcy they say 49% of a bk filing in 2yr take it FWIW
0 · Reply
looking4aprty
looking4aprty May. 12 at 2:37 PM
$QDEL you sure its going down because it looks like QDEL is headed towards 20 dollars man i hope you know what you're talking about and if you're short good luck
1 · Reply
Staska
Staska May. 12 at 2:35 PM
$QDEL https://seekingalpha.com/article/4902804-quidelortho-a-growing-stable-business-with-a-significant-mispricing
0 · Reply
looking4aprty
looking4aprty May. 12 at 2:34 PM
0 · Reply
looking4aprty
looking4aprty May. 12 at 2:34 PM
$QDEL im not sure but it looks like it about to take off
0 · Reply
gvnbykplt1903
gvnbykplt1903 May. 11 at 7:48 PM
0 · Reply
BullYa
BullYa May. 11 at 7:47 PM
$QDEL 📉 single digit is arriving 📉🔥
0 · Reply
scott52
scott52 May. 11 at 4:33 PM
$QDEL Damn. Will this thing ever stop going down? Glad i don't own it. But curious if/when it hits a buy point. Anyone? thoughts? Is there a price it becomes a must buy?
0 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 12:44 PM
$QDEL Current Stock Price: $10.80 Contracts to trade: $10.0 QDEL May 15 2026 Call Entry: $1.07 Exit: $1.96 ROI: 83% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
anachartanalyst
anachartanalyst May. 7 at 1:02 PM
$QDEL https://anachart.com/wp-content/uploads/2026/05/1778158890_soc-img.jpg
0 · Reply
AXLFI_HQ
AXLFI_HQ May. 6 at 11:45 PM
$QDEL Consumer goods and downstream manufacturers face persistent margin pressure from elevated energy and logistics costs driven by geopolitical conflict, forcing downward earnings revisions despite stable or declining volumes. Learn more: https://axlfi.com/themes/215
0 · Reply
SuperGreenToday
SuperGreenToday May. 5 at 9:35 PM
$QDEL Share Price: $11.68 Contract Selected: Dec 18, 2026 $10 Calls Buy Zone: $2.80 – $3.46 Target Zone: $5.10 – $6.23 Potential Upside: 72% ROI Time to Expiration: 226 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 5 at 8:16 PM
$QDEL Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$1.35 down -610.53% YoY • Reported revenue of $619.8M down -10.54% YoY • QuidelOrtho updated its full-year 2026 guidance, lowering total revenues to $2.7B, adjusted EBITDA to $615M, and adjusted diluted EPS to $1.80-$2.00, reflecting Q1 performance and China market dynamics.
0 · Reply
Paardaam
Paardaam May. 5 at 8:12 PM
$QDEL was this sucker not already hit by pre release of the earnings weeks ago ? What is this new reaction now for ? Jesus!!!!! What a mess.
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT May. 5 at 7:52 PM
$QDEL i've got some interest in this name, but not willing to pull the trigger staring at earnings in about 10 min
0 · Reply
BullYa
BullYa May. 5 at 6:45 PM
0 · Reply
Estimize
Estimize May. 4 at 1:09 PM
Wall St is expecting 0.03 EPS for $QDEL Q2 [Reporting 07/30 AMC] http://www.estimize.com/intro/qdel?chart=historical&metric_name=eps&utm_co
0 · Reply
StockBraker
StockBraker May. 4 at 12:52 PM
$QDEL Reports tomorrow after the market closes. "The Company currently expects preliminary unaudited revenue, as reported, of $615-$620 million for the first quarter of 2026. This preliminary unaudited revenue was primarily driven by a weaker respiratory season, with U.S. Influenza-like Illness visits down by approximately 30% compared to the first quarter of 20251, along with slower China distributor sales that the Company believes is related to the proposed China National Health Security Administration ("NHSA") reimbursement rate reductions. Additionally, certain EMEA orders were delayed by the Middle East conflict, negatively impacting first quarter revenue."
0 · Reply
debbiekatz
debbiekatz May. 1 at 4:34 PM
$QDEL at 12.47. i posted at 12.01 but if you were watching it could've bought under 11 around 4/23. if you keep swinging it, should get back to 16 next.
0 · Reply
HappyStockholder
HappyStockholder May. 1 at 12:46 PM
$QDEL I’m sure glad I stumbled upon this juggernaut last week, thanks to the naysayers. I’m up big. $3.3 billion enterprise value. Absolutely no risk of bankruptcy. Wouldn’t be surprised to see $14 after next week’s earnings report.
0 · Reply
Paardaam
Paardaam Apr. 30 at 3:42 PM
$QDEL the pain of holding this bag is at an undefined territory . Beyond excruciating.. defies logic .
1 · Reply
gvnbykplt1903
gvnbykplt1903 Apr. 30 at 3:17 AM
$QDEL unbelievable they bought 6 billion dollars for ortho 5 years ago and todays market cap 800 million dollars . its like you buying a house worth of 600 thousands dollars and 5 years later house worth of 80 thousand dollars. is this a joke ?
1 · Reply